Reply to thread

My experience with significant lowering of prolactin using cabergoline (Dostinex®) is in a study population of older men and the vast majority were being treated for prostate cancer.  This is a seriously different cohort of men than in the publication cited above.  I am attaching the full paper for your interest.


Back
Top